A critical discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial malignant inhibitor protein is frequently disabled in many forms of tumors, leading https://bookmarkingalpha.com/story21947112/mini-antibodies-revive-tumor-suppressor-p53-new-new-hope-for-cancer-management